Sign up now and fund within 24h to get free NKE, GPRO or DBX stock. T&Cs apply.
Redeem Now
Stake logo
LoginOpen an accountSign up
​

EBS

Trade Now
Compare

Emergent BioSolutions Inc

1 day chart

Kickstart your portfolio with a U.S. stock on us

Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.

Sign up and fund a new Wall St account and get a full U.S. share.

T&Cs apply
Claim now
Kickstart your portfolio with a U.S. stock on us

About EBS

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.

Market Capitalisation

$599.25M

Price-earnings ratio

-

Dividend yield

0.00%

Volume

568.16K

High today

$11.85

Low today

$11.34

Open price

$11.77

52-week high

$13.41

52-week low

$4.02

Ready to start your investing journey with Stake?

Open an account

EBS FAQs

Buying EBS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Emergent BioSolutions Inc in minutes.
  1. Sign up with some I.D. and zero paperwork
  2. Add funds to your account
  3. Make your first investment in EBS
The ticker symbol for Emergent BioSolutions Inc is EBS.
One share of EBS is valued at $11.35 as of 13 December 2025.
As of 13 December 2025 Emergent BioSolutions Inc has a market cap of $599.25M.
The Price to Earnings ratio of EBS is 9.06.
The Earnings Per Share of EBS is $1.29.
The Emergent BioSolutions Inc 52-week high stock price is $13.41.
The Emergent BioSolutions Inc 52-week low stock price is $4.02.
Yes, the Stake investing platform allows you to buy EBS shares and over 9,500 more stocks and ETFs on Wall St.

This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in EBS
on Stake

Buy EBS from US$3 brokerage

Invest in 9,500+ U.S. stocks and ETFs

Own a slice of EBS from only US$10 with fractional shares

Get started
Stake app chart
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
EBS related stocks
Stake logo
Over 12,000 5-star reviews
App Store logoGoogle Play logo

Product

Account

Learn

Company

Legal

Contact Us

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.
Region: nz

Stakeshop Pty Ltd is registered as an overseas company in New Zealand (NZBN: 9429047452152), and is registered as a Financial Service Provider under the Financial Service Providers (Registration and Dispute Resolution) Act 2008 (No. FSP774414). We hold a full licence issued by the Financial Markets Authority to provide a financial advice service under the Financial Markets Conduct Act 2013. However, the content on this website has not been prepared to take into account any of your individual objectives, financial situation or needs. To the extent you require further information about the relevant New Zealand legislation that may apply, or require specific advice, please contact your legal and/or financial adviser (as appropriate). The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Terms & Conditions, Privacy Policy, Financial Advice Disclosure and Disclaimers before deciding to use or invest on Stake. By using the Stake website or service in any way, you agree to our Privacy Policy and Terms & Conditions All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake is a registered trademark under class 36 (New Zealand).

Copyright © 2025 Stake. All rights reserved.